208 related articles for article (PubMed ID: 24650032)
1. MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.
Zhang KL; Zhou X; Han L; Chen LY; Chen LC; Shi ZD; Yang M; Ren Y; Yang JX; Frank TS; Zhang CB; Zhang JX; Pu PY; Zhang JN; Jiang T; Wagner EJ; Li M; Kang CS
Mol Cancer; 2014 Mar; 13():63. PubMed ID: 24650032
[TBL] [Abstract][Full Text] [Related]
2. Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas.
Zhang KL; Han L; Chen LY; Shi ZD; Yang M; Ren Y; Chen LC; Zhang JX; Pu PY; Kang CS
Cancer Lett; 2014 Jan; 342(1):139-49. PubMed ID: 24012640
[TBL] [Abstract][Full Text] [Related]
3. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling.
Chen L; Han L; Zhang K; Shi Z; Zhang J; Zhang A; Wang Y; Song Y; Li Y; Jiang T; Pu P; Jiang C; Kang C
Neuro Oncol; 2012 Aug; 14(8):1026-36. PubMed ID: 22649212
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.
Peng Y; He X; Chen H; Duan H; Shao B; Yang F; Li H; Yang P; Zeng Y; Zheng J; Li Y; Hu J; Lin L; Teng L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061180
[TBL] [Abstract][Full Text] [Related]
5. miR-424 induces apoptosis in glioblastoma cells and targets AKT1 and RAF1 oncogenes from the ERBB signaling pathway.
Gheidari F; Arefian E; Adegani FJ; Kalhori MR; Seyedjafari E; Kabiri M; Teimoori-Toolabi L; Soleimani M
Eur J Pharmacol; 2021 Sep; 906():174273. PubMed ID: 34153339
[TBL] [Abstract][Full Text] [Related]
6. A Novel Role for MiR-520a-3p in Regulating EGFR Expression in Colorectal Cancer.
Zhang R; Liu R; Liu C; Niu Y; Zhang J; Guo B; Zhang CY; Li J; Yang J; Chen X
Cell Physiol Biochem; 2017; 42(4):1559-1574. PubMed ID: 28738328
[TBL] [Abstract][Full Text] [Related]
7. The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.
Gheidari F; Arefian E; Saadatpour F; Kabiri M; Seyedjafari E; Teimoori-Toolabi L; Soleimani M
Mol Biol Rep; 2022 Dec; 49(12):11855-11866. PubMed ID: 36219319
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
9. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression.
Li C; Zhao J; Sun W
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):9. PubMed ID: 32756923
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
11. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
Eller JL; Longo SL; Hicklin DJ; Canute GW
Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
[TBL] [Abstract][Full Text] [Related]
12. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
13. Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.
Nitta Y; Shimizu S; Shishido-Hara Y; Suzuki K; Shiokawa Y; Nagane M
Cancer Med; 2016 Mar; 5(3):486-99. PubMed ID: 26778701
[TBL] [Abstract][Full Text] [Related]
14. miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma.
Rao SA; Arimappamagan A; Pandey P; Santosh V; Hegde AS; Chandramouli BA; Somasundaram K
PLoS One; 2013; 8(5):e63164. PubMed ID: 23690991
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-139-3p suppresses growth and metastasis of glioblastoma via inhibition of NIN1/RPNI2 binding protein 1 homolog.
Shi L; Yuan Y; Li HY
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4264-4274. PubMed ID: 31173298
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells.
Gomez Zubieta DM; Hamood MA; Beydoun R; Pall AE; Kondapalli KC
Cell Commun Signal; 2017 Dec; 15(1):55. PubMed ID: 29268774
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.
Liu N; Xia WY; Liu SS; Chen HY; Sun L; Liu MY; Li LF; Lu HM; Fu YJ; Wang P; Wu H; Gao JX
Sci Rep; 2016 Feb; 6():20489. PubMed ID: 26841847
[TBL] [Abstract][Full Text] [Related]
19. miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.
Liu Z; Jiang Z; Huang J; Huang S; Li Y; Yu S; Yu S; Liu X
Int J Oncol; 2014 May; 44(5):1571-80. PubMed ID: 24603851
[TBL] [Abstract][Full Text] [Related]
20. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
